INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "ANTIGENIC PEPTIDE HAVING MULTIPLE KRAS VARIANT PEPTIDES LINKED THERETO, NUCLEIC ACID ENCODING SAME AND USE THEREOF"

GENEVA, Oct. 5 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/004112) for "ANTIGENIC PEPTIDE HAVING MULTIPLE KRAS VARIANT PEPTIDES LINKED THERETO, NUCLEIC ACID ENCODING SAME, AND USE THEREOF" on Mar 28, 2025. With publication no. WO/2025/206850, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)....